A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
8
Citations
NaN
KQI